Champions Oncology, Inc.
CSBR · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $10 | $10 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $9 | $11 | $16 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $21 | $21 | $22 | $20 |
| Property Plant & Equip (Net) | $8 | $9 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $9 | $10 | $10 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $31 | $32 | $31 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $4 | $5 |
| Short-Term Debt | $2 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $12 | $14 | $15 | $11 |
| Other Curr. Liab. | $2 | $2 | $3 | $2 |
| Total Curr. Liab. | $22 | $23 | $24 | $20 |
| LT Debt | $4 | $4 | $5 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $4 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $6 | $6 |
| Total Liabilities | $26 | $27 | $29 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$80 | -$80 | -$80 | -$78 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $84 | $84 | $84 | $84 |
| Total Equity | $4 | $4 | $4 | $5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $31 | $32 | $31 |
| Net Debt | -$3 | -$5 | -$4 | $3 |